As of September 2024, Hanall Biopharma has a market cap of $1.39B. This makes Hanall Biopharma the world's 6465th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.35B | -20.54% |
2023 | $1.70B | 148.88% |
2022 | $684.82M | -15.44% |
2021 | $809.86M | -43.87% |
2020 | $1.44B | 3.31% |
2019 | $1.40B | 0.28% |
2018 | $1.39B | 48.36% |
2017 | $938.74M | 85.55% |
2016 | $505.92M | 0.00% |
2015 | $505.92M | 242.45% |
2014 | $147.74M | -7.91% |
2013 | $160.43M | -51.79% |
2012 | $332.79M | - |